source
- Kura Oncology launches Caspian Therapeutics to develop menin-inhibitor diabetes drug with $50M fundingKura Oncology has spun out a new biotech called Caspian Therapeutics to focus on menin inhibitors for diabetes and other cardiometabolic diseases. The company’s lead candidate, code-named KO-7246,…
- Research on orexin and narcolepsy earns Lasker Award for Yanagisawa and MignotMasashi Yanagisawa and Emmanuel Mignot were honored with the Lasker Award for their work uncovering the role of orexin in narcolepsy. The award was announced on September 9, 2026. Their research b…